Skip to main content
. 2022 Jan 31;7(3):215–221. doi: 10.1136/svn-2021-001030

Table 2.

Discrepancies between postmortem non-neuropathological findings and clinical diagnoses, and discrepancies between postmortem neuropathological findings and the last premortem CT scan

Discrepancy Postmortem non-neuropathological findings
Number (N)=534
Class I discrepancy 8 (1.5%) malignancies
68 cases of (12.7%) thromboembolic events: in vivo non-diagnosed thrombosis in the femoral vein or in the periprostatic and periuterine venous plexus, embolus in the lung—without any antithrombotic therapy
36 cases of (6.7%) in vivo non-diagnosed pneumonia, without any antibiotic therapy
Class II discrepancy 12 cases of (2.3%) thromboembolic events: in vivo non-diagnosed thrombosis in the femoral vein or in the periprostatic and periuterine venous plexus, embolus in the lung—with prophylactic antithrombotic therapy
37 cases of (6.9%) in vivo non-diagnosed pneumonia, but prophylactic antibiotic therapy
Class III discrepancy 169 (31.6%) benign findings (cysts, myoma, etc)
Postmortem neuropathological findings in patients with ischaemia
Number (N)=189
Class I discrepancy 66 (34.9%) ischaemic lesions on the premortem CT scan, but haemorrhagic transformation of an infarct on brain autopsy